February 16th - $Vaccinex (VCNX.US)$ is about to implement a 1-for-14 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 20th, 2024.
$Vaccinex (VCNX.US)$ rose 2.94% and closed at $0.875 on February 15th with a turnover of $595.79K. $Vaccinex (VCNX.US)$ now has a total market capitalization of $14.29 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.